MRD in AML: The Role of New Techniques

In the context of precision medicine, assessment of minimal residual disease (MRD) has been used in acute myeloid leukemia (AML) to direct individual treatment programs, including allogeneic stem cell transplantation in patients at high-risk of relapse. One of the limits of this approach has been in...

Descripción completa

Detalles Bibliográficos
Autores principales: Voso, Maria Teresa, Ottone, Tiziana, Lavorgna, Serena, Venditti, Adriano, Maurillo, Luca, Lo-Coco, Francesco, Buccisano, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664148/
https://www.ncbi.nlm.nih.gov/pubmed/31396481
http://dx.doi.org/10.3389/fonc.2019.00655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664148/
https://www.ncbi.nlm.nih.gov/pubmed/31396481
http://dx.doi.org/10.3389/fonc.2019.00655

Ejemplares similares